Inogen Announces Fourth Quarter and Full Year 2019 Financial Results and Updates 2020 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Inogen (INGN) Misses Q4 EPS by 16c, Revenues Miss; Offers FY20 Revenue Guidance Below Consensus
February 25, 2020 4:43 PM ESTInogen (NASDAQ: INGN) reported Q4 EPS of ($0.06), $0.16 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $78.9 million versus the consensus estimate of $86.42 million.
Fourth Quarter 2019 Highlights
Total revenue of $78.9 millionInogen One G5® units accounted for over 40% of total unit volume in the periodLimited launch of the Inogen Tidal Assist® Ventilator (TAV®) product in December 2019As of December 31, 2019, the Company had 329 inside direct-to-consumer sales representatives and 17 outside physician sales representativesWhile 2019 was a challenging year, revenue increased 8.2% over the prior year, excluding the... More
